|
Merida's lead programme, MER511, is in Phase I development for Graves' disease and thyroid eye disease (TED).
|
 |
|
The Australia-based STAREE trial is the first of its kind demonstrating the preventative effects of statins in older patients.
|
|
|
The approval will likely expand Lilly’s cardiometabolic empire as it looks to stay ahead of rival Novo Nordisk.
|
|
|
Several treatment guidelines worldwide recommend the use of SGLT2 inhibitors as a treatment for all types of heart failure.
|
|
|
The benefits of intensive LDL-C lowering with Repatha (evolocumab) may extend beyond cardiovascular event prevention to reducing mortality.
|
|
|
The transaction would see Teva obtain worldwide rights to Igalmi and the investigational BXCL501.
|
|
|
Aficamten improves cardiac structure and diastolic function, strengthening its case as a targeted therapy for nonobstructive HCM.
|
|
